A perfect 10 in 2022 for Manchester's Innovation Factory

Ten brand new Manchester-based biomedical, science and engineering companies have been created over the past year by The University of Manchester Innovation Factory, producing cutting-edge technology and services which will benefit societies around the world.

In addition to forming these new IP-rich businesses, the Innovation Factory, which is dedicated to driving the commercialisation of innovations and intellectual property originating from The University of Manchester (UoM), secured an impressive £6.4M of first investment into Manchester-based spinout companies as well as £4.9M in UoM licensing income.  

Andrew Wilkinson, Innovation Factory Chief Executive, said: “We are proud to help the nation’s most visionary researchers and scholars transform their ideas and theories into a form that can be used to benefit people from all parts of the world.  Manchester has always been the birthplace of great ideas and that pulse of innovation is as strong as ever.”

In 2021, the Innovation Factory was instrumental in facilitating the formation of Northern Gritstone through a partnership with the Universities of Leeds, Manchester and Sheffield. Northern Gritstone is an investment vehicle determined to be one of the largest investors into academic spinouts in the UK.

The newly formed businesses are:

  • Apini Therapeutics Ltd – Novel Small Molecule Therapeutics for the treatment of inflammatory diseases without induction of immune suppression
  • Holiferm Ltd – Fermentation technology with initial focus on biosurfactants
  • Imperagen Ltd – An AI prediction of enzyme optimisation
  • Mi-Trial Ltd – Clinical trial companion system and app
  • Music in Mind Remote Ltd – Digital platform for providing music to people with dementia
  • Nexsys Ltd – Online platform for water management and planning
  • Polynerve Ltd – Synthetic polymer nerve conduit
  • Recon2 Ltd – System for measurement of recycled plastic content in packaging
  • Sebomix Ltd – A rapid, non-invasive test for the diagnosis of Parkinson’s Disease and a wide range of other indications
  • Urban 360 Ltd – Intelligence to improve urban sustainability

To find out more about the Innovation Factory’s work and the projects they are supporting, visit www.uominnovationfactory.com

Policy areas

Related case studies

Reducing blood transfusions to lower patient risk, reduce costs and save lives

More than half a million people in the UK receive a blood transfusion each year and demand is increasing. Our ageing population, and a stringent donor selection process, mean the supply of blood is limited. 40% fewer new donors came forward last year compared with a decade ago. Recognising these challenges, researchers at the University of Edinburgh have shown the benefits of reducing the use of blood transfusions in intensive care and surgery.

Read more >

Media Enquiries
Policy Enquiries

Follow us on Twitter